|  Help  |  About  |  Contact Us

Publication : Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation.

First Author  Reynolds JM Year  2015
Journal  Immunity Volume  42
Issue  4 Pages  692-703
PubMed ID  25888259 Mgi Jnum  J:229778
Mgi Id  MGI:5754452 Doi  10.1016/j.immuni.2015.03.008
Citation  Reynolds JM, et al. (2015) Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation. Immunity 42(4):692-703
abstractText  The interleukin-17 (IL-17) family of cytokines has emerged as a critical player in inflammatory diseases. Among them, IL-25 has been shown to be important in allergic inflammation and protection against parasitic infection. Here we have demonstrated that IL-17B, a poorly understood cytokine, functions to inhibit IL-25-driven inflammation. IL-17B and IL-25, both binding to the interleukin-17 receptor B (IL-17RB), were upregulated in their expression after acute colonic inflammation. Individual inhibition of these cytokines revealed opposing functions in colon inflammation: IL-25 was pathogenic but IL-17B was protective. Similarly opposing phenotypes were observed in Citrobacter rodentium infection and allergic asthma. Moreover, IL-25 was found to promote IL-6 production from colon epithelial cells, which was inhibited by IL-17B. Therefore, our data demonstrate that IL-17B is an anti-inflammatory cytokine in the IL-17 family.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

21 Bio Entities

0 Expression